Information  X 
Enter a valid email address

Genesis Emerging (GSS)

  Print   

Thursday 23 May, 2019

Genesis Emerging

Circular including Notice of Class Meeting & EGM

RNS Number : 0344A
Genesis Emerging Markets Fund Ld
23 May 2019
 


Genesis Emerging Markets Fund Limited (the 'Company')

Legal Entity Identifier: 213800HWWQPUJ4K1GS84

 

 

Proposed new investment management agreement and ancillary matters

 

Notice of class meeting of participating shareholders and notice of extraordinary general meeting

 

The Company has today published a shareholder circular including a notice convening a class meeting of holders of the Company's participating shares at 1.00 p.m. and a notice of an extraordinary general meeting of the Company at 1.15 p.m or as soon thereafter as the class meeting concludes on 21st June 2019 at the offices of J.P. Morgan, 60 Victoria Embankment, London EC4Y 0JP. 

 

The purpose of the meetings are to approve a new investment management agreement between the Company and Genesis Investment Management, LLP and certain ancillary matters, being the ratification of the Company's existing custody agreement with JPMorgan Chase Bank, N.A. and proposed amendments to the Company's articles of incorporation.

 

In accordance with Listing Rule 9.6.3, the shareholder circular, notice of meetings and accompanying forms of proxy have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM

 

The shareholder circular, notice of meetings and accompanying forms of proxy will also shortly be available from the Company's website at: www. genesisemf.com

 

 

For further information, please contact:

 

J.P. Morgan Administration Services (Guernsey) Limited

Company Secretary

01481 758 620

 

23rd May 2019

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NOGLLFVVEAIVFIA

a d v e r t i s e m e n t